DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Wacker Chemie AG

DB:WCH Stock Report

Market Cap: €4.6b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Wacker Chemie Valuation

Is WCH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WCH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: WCH (€91.3) is trading below our estimate of future cash flow value (€393.23)

Significantly Below Future Cash Flow Value: WCH is trading below future cash flow value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for WCH?

Key metric: As WCH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for WCH. This is calculated by dividing WCH's market cap by their current revenue.
What is WCH's PS Ratio?
PS Ratio0.8x
Sales€5.52b
Market Cap€4.55b
WCH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1x
Enterprise Value/EBITDA9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does WCH's PS Ratio compare to its peers?

  • Price to Earnings
  • Price to Sales
  • Price to Book
The above table shows the PS ratio for WCH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.7x
EVK Evonik Industries
0.6x1.78%€8.5b
1COV Covestro
1x8.30%€12.5b
SY1 Symrise
2.5x4.82%€12.1b
ACT AlzChem Group
2.8x11.48%€1.6b
WCH Wacker Chemie
0.8x2.79%€4.6b

Price-To-Sales vs Peers: WCH is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (1.7x).


Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

  • Price to Earnings
  • Price to Sales
  • Price to Book

Fetching historical data


Price to Sales Ratio vs Industry

How does WCH's PS Ratio compare vs other companies in the DE Chemicals Industry?

  • Price to Earnings
  • Price to Sales
  • Price to Book
2 CompaniesPrice / SalesEstimated GrowthMarket Cap
7M8 EcoRub
0.1xn/aUS$25.54m
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
WCH 0.8xIndustry Avg. 1.1xNo. of Companies5PS00.61.21.82.43+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: WCH is good value based on its Price-To-Sales Ratio (0.8x) compared to the European Chemicals industry average (1.1x).


Price to Sales Ratio vs Fair Ratio

What is WCH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WCH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: WCH is expensive based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst WCH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€91.30
€90.72
-0.64%
11.13%€104.00€62.00n/a12
Sep ’27€93.00
€89.55
-3.71%
11.49%€104.00€60.00n/a12
Aug ’27€88.25
€90.05
+2.04%
12.93%€110.00€60.00n/a12
Jul ’27€90.00
€88.97
-1.14%
15.46%€110.00€60.00n/a14
Jun ’27€101.50
€87.04
-14.24%
16.78%€110.00€60.00n/a14
May ’27€91.45
€81.43
-10.96%
17.77%€110.00€50.00n/a14
Apr ’27€83.50
€73.50
-11.98%
14.92%€96.00€50.00n/a14
Mar ’27€80.20
€71.57
-10.76%
16.68%€96.00€50.00n/a14
Feb ’27€67.50
€69.57
+3.07%
14.14%€88.00€50.00n/a14
Jan ’27€68.60
€67.36
-1.81%
16.15%€88.00€50.00n/a14
Dec ’26€65.40
€67.36
+2.99%
15.76%€88.00€50.00n/a14
Nov ’26€68.00
€68.54
+0.79%
17.51%€95.00€50.00n/a13
Oct ’26€63.70
€71.15
+11.70%
22.65%€113.00€50.00n/a13
Sep ’26€64.90
€76.07
+17.21%
20.36%€113.00€52.00€93.0014
Aug ’26€64.50
€78.21
+21.26%
20.66%€113.00€52.00€88.2514
Jul ’26€62.05
€82.40
+32.80%
21.40%€129.00€57.00€90.0015
Jun ’26€62.50
€85.80
+37.28%
18.43%€129.00€70.00€101.5015
May ’26€66.70
€89.07
+33.53%
18.12%€129.00€70.00€91.4515
Apr ’26€75.24
€93.80
+24.67%
15.60%€129.00€74.00€83.5015
Mar ’26€69.54
€97.93
+40.83%
18.61%€133.00€74.00€80.2015
Feb ’26€66.68
€101.27
+51.87%
18.74%€133.00€74.00€67.5015
Jan ’26€69.96
€113.20
+61.81%
12.42%€135.00€87.00€68.6015
Dec ’25€70.64
€114.40
+61.95%
12.50%€135.00€87.00€65.4015
Nov ’25€78.34
€119.13
+52.06%
17.58%€178.00€87.00€68.0016
Oct ’25€89.48
€124.47
+39.10%
14.63%€178.00€98.00€63.7015
Sep ’25€86.22
€126.80
+47.07%
13.49%€178.00€100.00€64.9015
AN
AnalystPriceTarget
AnalystPriceTarget
Member since 2015
€90.37
Fair Value
1.0% overvalued intrinsic discount
12
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 16:48
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Wacker Chemie AG is covered by 31 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Laura Lopez PinedaBaader Helvea Equity Research

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide